Hospital
Sutter Valley Hospitals
Sutter Valley Hospitals was paid $19.42M by Medicaid between Jan 2018 and Dec 2024, across 195 billing codes. Its largest line is 0450, Emergency room services — 27% of everything it billed.
33Billing provider infoSUTTER VALLEY HOSPITALS
TRACY, CA 95376
TRACY, CA 95376
33aNPI1821442864assigned 04/15/2016
33bProvider typeGeneral Acute Care Hospital
28Total paid$19.42M
24GClaims517,711
24DCodes billed195
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in California
Rank by total paid#127 of 410
Median peer was paid$6.90M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 87,550 | $3.25M | |
| 2019 | 78,150 | $2.75M | |
| 2020 | 57,937 | $2.34M | |
| 2021 | 73,310 | $3.48M | |
| 2022 | 75,935 | $2.37M | |
| 2023 | 93,774 | $3.00M | |
| 2024incomplete | 51,055 | $2.23M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 27% | 76,922 | 68,904 | $5.28M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 5.6% | 3,604 | 3,480 | $1.08M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 4.2% | 9,624 | 8,814 | $809K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 2.6% | 3,186 | 3,166 | $513K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.4% | 3,245 | 3,123 | $469K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.4% | 3,017 | 2,966 | $463K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2.2% | 7,337 | 6,397 | $435K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 2.2% | 4,245 | 3,851 | $421K |
| 80053 | Comprehensive metabolic panel | 2.0% | 34,023 | 31,030 | $392K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.9% | 12,311 | 11,546 | $378K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.9% | 2,534 | 2,450 | $366K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.9% | 8,988 | 8,230 | $365K |
183 more codes
| Z7502 | 1.7% | 8,935 | $332K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.6% | 5,059 | $303K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.5% | 36,533 | $295K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.4% | 3,115 | $269K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1.2% | 2,480 | $224K |
| 97139 | 1.2% | 8,077 | $224K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.1% | 2,367 | $215K |
| 71045 | Radiologic examination, chest; single view | 1.0% | 12,768 | $196K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.0% | 279 | $195K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 2,048 | $176K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 4,339 | $167K |
| 99283 | Emergency room visit (moderate) | <1% | 1,274 | $166K |
| 0250 | <1% | 16,964 | $164K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,988 | $162K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 1,038 | $159K |
| J3490 | Unclassified drugs | <1% | 7,726 | $149K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 610 | $148K |
| 82077 | <1% | 1,468 | $147K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,654 | $140K |
| 99285 | Emergency room visit (most serious) | <1% | 461 | $134K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,273 | $119K |
| 76830 | Ultrasound, transvaginal | <1% | 1,396 | $118K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 2,698 | $113K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 7,710 | $111K |
| 84484 | <1% | 11,130 | $108K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 153 | $107K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 427 | $101K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 1,045 | $101K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 783 | $99K |
| 83690 | <1% | 12,997 | $99K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 10,019 | $98K |
| 0270 | <1% | 3,253 | $96K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 8,920 | $95K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 309 | $93K |
| 83880 | <1% | 2,711 | $84K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,217 | $84K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,603 | $83K |
| 0762 | <1% | 117 | $83K | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,028 | $83K |
| 99199 | Unlisted special service, procedure or report | <1% | 685 | $83K |
| T1999 | Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" | <1% | 5,706 | $76K |
| 76801 | <1% | 894 | $74K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 2,827 | $71K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 312 | $69K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 955 | $65K |
| 64483 | <1% | 155 | $61K | |
| 87040 | <1% | 5,292 | $61K | |
| 73562 | <1% | 2,167 | $61K | |
| 73630 | <1% | 1,980 | $60K | |
| 80143 | <1% | 671 | $59K | |
| 73610 | <1% | 1,646 | $53K | |
| 97799 | <1% | 1,732 | $52K | |
| 80179 | <1% | 615 | $52K | |
| 81001 | <1% | 13,248 | $50K | |
| 73030 | <1% | 1,684 | $50K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 1,029 | $50K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 1,028 | $49K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,828 | $48K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,004 | $47K |
| 71250 | <1% | 334 | $43K | |
| 76770 | <1% | 445 | $42K | |
| 83605 | <1% | 3,979 | $41K | |
| 85379 | <1% | 3,575 | $39K | |
| 81025 | <1% | 7,151 | $39K | |
| 82553 | <1% | 3,401 | $38K | |
| 72100 | <1% | 966 | $35K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 832 | $35K |
| 84702 | <1% | 2,082 | $35K | |
| 0510 | <1% | 920 | $34K | |
| 73130 | <1% | 975 | $32K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 2,972 | $32K |
| 85730 | <1% | 4,804 | $31K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,443 | $31K |
| 87400 | <1% | 3,551 | $31K | |
| 97750 | <1% | 490 | $29K | |
| 0160 | <1% | 21 | $28K | |
| 0750 | <1% | 232 | $27K | |
| 87430 | <1% | 2,286 | $27K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 169 | $26K |
| 82550 | <1% | 3,755 | $25K | |
| 85610 | <1% | 6,069 | $25K | |
| 87186 | <1% | 2,155 | $25K | |
| 84703 | <1% | 3,810 | $24K | |
| 76642 | <1% | 277 | $24K | |
| 73110 | <1% | 639 | $24K | |
| 0500F | <1% | 73 | $24K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 492 | $23K |
| 99070 | <1% | 738 | $23K | |
| 72110 | <1% | 409 | $21K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,859 | $20K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,014 | $19K |
| 81003 | <1% | 7,118 | $19K | |
| 87081 | <1% | 1,960 | $19K | |
| 99205 | Prolong outpt/office vis | <1% | 133 | $18K |
| 87077 | <1% | 1,800 | $18K | |
| 93971 | <1% | 156 | $18K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 379 | $17K |
| 0761 | <1% | 386 | $17K | |
| 74018 | <1% | 533 | $16K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 1,414 | $16K |
| 64484 | <1% | 49 | $14K | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,033 | $12K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,452 | $12K |
| 83735 | <1% | 2,043 | $12K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $11K |
| 0361 | <1% | 411 | $11K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,353 | $11K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 606 | $10K |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 1,102 | $9K |
| Z7610 | <1% | 940 | $9K | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 1,833 | $9K |
| 70496 | <1% | 44 | $8K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 838 | $8K |
| 73140 | <1% | 349 | $7K | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 511 | $7K |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 78 | $7K |
| 70498 | <1% | 38 | $7K | |
| 82947 | <1% | 1,305 | $6K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 17 | $6K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 69 | $6K |
| 99401 | <1% | 277 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 630 | $5K |
| 94644 | <1% | 180 | $5K | |
| 72131 | <1% | 29 | $5K | |
| 86901 | <1% | 1,197 | $5K | |
| 90715 | <1% | 88 | $5K | |
| 76536 | <1% | 70 | $5K | |
| 86900 | <1% | 1,215 | $5K | |
| 87420 | <1% | 928 | $5K | |
| 96156 | <1% | 250 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,225 | $4K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 42 | $4K |
| 97803 | <1% | 131 | $4K | |
| 72040 | <1% | 107 | $4K | |
| 73221 | <1% | 15 | $4K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 139 | $4K |
| 73560 | <1% | 130 | $4K | |
| 72141 | <1% | 16 | $4K | |
| 86140 | <1% | 482 | $3K | |
| 73502 | <1% | 78 | $3K | |
| 87088 | <1% | 320 | $3K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 300 | $2K |
| 76870 | <1% | 40 | $2K | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 246 | $2K |
| 71020 | <1% | 53 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 57 | $2K |
| 77066 | Tomosynthesis, mammo | <1% | 13 | $2K |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 143 | $2K |
| 72050 | <1% | 42 | $2K | |
| 0324 | <1% | 29 | $2K | |
| 70486 | <1% | 13 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 143 | $2K |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 89 | $1K |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 66 | $1K |
| 85651 | <1% | 473 | $1K | |
| 71100 | <1% | 40 | $1K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 18 | $975.99 |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 61 | $878.94 |
| 75571 | <1% | 13 | $855.02 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 26 | $805.79 |
| 96151 | <1% | 53 | $793.41 | |
| 73590 | <1% | 31 | $783.84 | |
| 82803 | <1% | 46 | $666.07 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 288 | $636.03 |
| J1815 | Injection, insulin, per 5 units | <1% | 70 | $524.60 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 70 | $453.40 |
| 86331 | <1% | 48 | $452.06 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 28 | $343.39 |
| 88342 | <1% | 15 | $303.45 | |
| 87210 | <1% | 53 | $238.19 | |
| 87147 | <1% | 31 | $188.38 | |
| 88313 | <1% | 15 | $180.32 | |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 16 | $76.96 |
| J2704 | Injection, propofol, 10 mg | <1% | 26 | $67.60 |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 13 | $58.71 |
| 86850 | <1% | 15 | $52.08 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 15 | $50.60 |
| 0250R | 0% | 26 | $0.00 | |
| Q4051 | Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies) | 0% | 41 | $0.00 |
| 94729 | 0% | 13 | $0.00 | |
| 94726 | 0% | 13 | $0.00 | |
| 94060 | 0% | 13 | $0.00 | |
| 0272 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTERRA, PAIGE (CFO)
| Provider | Location | Paid |
|---|---|---|
| Sutter Valley Hospitals | Modesto, CA | $76.21M |
| Sutter Valley Hospitals | Los Banos, CA | $26.09M |
| Sutter Coast Hospital | Crescent City, CA | $21.67M |
| Sutter Valley Hospitals | Los Banos, CA | $17.26M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.